• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

定量分析 GNE 肌病肌肉活检中的凝集素荧光。

Quantification of lectin fluorescence in GNE myopathy muscle biopsies.

机构信息

Medical Genetics Branch, National Human Genome Research Institute, National Institutes of Health, 10 Center Drive, Bld. 10, Room 10C103 Bethesda, Maryland, 20892, USA.

Therapeutics for Rare and Neglected Diseases, National Center for Advancing Translational Sciences, National Institutes of Health, Bethesda, Maryland, USA.

出版信息

Muscle Nerve. 2018 Aug;58(2):286-292. doi: 10.1002/mus.26135. Epub 2018 Apr 23.

DOI:10.1002/mus.26135
PMID:29603301
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6105422/
Abstract

INTRODUCTION

GNE myopathy is an adult-onset muscle disorder characterized by impaired sialylation of (muscle) glycans, detectable by lectin histochemistry. We describe a standardized method to quantify (lectin-) fluorescence in muscle sections, applicable for diagnosis and response to therapy for GNE myopathy.

METHODS

Muscle sections were fluorescently labeled with the sialic acid-binding Sambucus nigra agglutinin (SNA) lectin and antibodies to sarcolemma residence protein caveolin-3 (CAV-3). Entire tissue sections were imaged in tiles and fluorescence was quantified.

RESULTS

SNA fluorescence co-localizing with CAV-3 was ∼50% decreased in GNE myopathy biopsies compared with muscle-matched controls, confirming previous qualitative results.

DISCUSSION

This quantitative fluorescence method can accurately determine sialylation status of GNE myopathy muscle biopsies. This method is adaptable for expression of other membrane-associated muscle proteins, and may be of benefit for disorders in which therapeutic changes in expression are subtle and difficult to assess by other methods. Muscle Nerve 58: 286-292, 2018.

摘要

简介

GNE 肌病是一种成人发病的肌肉疾病,其特征是(肌肉)糖链唾液酸化受损,可通过凝集素组织化学检测到。我们描述了一种标准化的方法来量化肌肉切片中的(凝集素)荧光,适用于 GNE 肌病的诊断和治疗反应。

方法

肌肉切片用唾液酸结合的黑接骨木凝集素(SNA)凝集素和肌膜驻留蛋白窖蛋白-3(CAV-3)抗体进行荧光标记。整个组织切片以瓷砖形式成像,并对荧光进行定量。

结果

与肌肉匹配的对照组相比,GNE 肌病活检中的 SNA 荧光与 CAV-3 共定位减少了约 50%,证实了之前的定性结果。

讨论

这种定量荧光方法可以准确确定 GNE 肌病肌肉活检的唾液酸化状态。该方法适用于其他膜相关肌肉蛋白的表达,对于其他方法难以评估的治疗表达变化细微的疾病可能有益。肌肉神经 58: 286-292, 2018.

相似文献

1
Quantification of lectin fluorescence in GNE myopathy muscle biopsies.定量分析 GNE 肌病肌肉活检中的凝集素荧光。
Muscle Nerve. 2018 Aug;58(2):286-292. doi: 10.1002/mus.26135. Epub 2018 Apr 23.
2
The glycomic sialylation profile of GNE Myopathy muscle cells does not point to consistent hyposialylation of individual glycoconjugates.GNE 肌病肌肉细胞的糖基化唾液酸化谱并未指向个别糖缀合物的一致性低唾液酸化。
Neuromuscul Disord. 2020 Aug;30(8):621-630. doi: 10.1016/j.nmd.2020.05.008. Epub 2020 Jun 4.
3
Safety, pharmacokinetics and sialic acid production after oral administration of N-acetylmannosamine (ManNAc) to subjects with GNE myopathy.GNE 肌病患者口服 N-乙酰甘露糖胺(ManNAc)后的安全性、药代动力学和唾液酸生成。
Mol Genet Metab. 2017 Sep;122(1-2):126-134. doi: 10.1016/j.ymgme.2017.04.010. Epub 2017 Apr 26.
4
Krebs von den Lungen 6 decreased in the serum and muscle of GNE myopathy patients.肺腺癌 6 在 GNE 肌病患者的血清和肌肉中减少。
Neuropathology. 2021 Feb;41(1):29-36. doi: 10.1111/neup.12703. Epub 2020 Nov 22.
5
Identification of a GNE homozygous mutation in a Han-Chinese family with GNE myopathy.鉴定一个汉族 GNE 肌病家系中的 GNE 基因纯合突变。
J Cell Mol Med. 2018 Nov;22(11):5533-5538. doi: 10.1111/jcmm.13827. Epub 2018 Aug 29.
6
Visualizing Muscle Sialic Acid Expression in the GNED207VTgGne-/- Cmah-/- Model of GNE Myopathy: A Comparison of Dietary and Gene Therapy Approaches.在GNE肌病的GNED207VTgGne-/- Cmah-/-模型中可视化肌肉唾液酸表达:饮食和基因治疗方法的比较
J Neuromuscul Dis. 2022;9(1):53-71. doi: 10.3233/JND-200575.
7
Mutation update for GNE gene variants associated with GNE myopathy.与GNE肌病相关的GNE基因突变更新
Hum Mutat. 2014 Aug;35(8):915-26. doi: 10.1002/humu.22583.
8
GNE myopathy: from clinics and genetics to pathology and research strategies.GNE 肌病:从临床和遗传学,到病理学和研究策略。
Orphanet J Rare Dis. 2018 May 2;13(1):70. doi: 10.1186/s13023-018-0802-x.
9
Mutation profile of the GNE gene in Japanese patients with distal myopathy with rimmed vacuoles (GNE myopathy).GNE 基因在伴有镶边空泡的远端肌病(GNE 肌病)日本患者中的突变谱。
J Neurol Neurosurg Psychiatry. 2014 Aug;85(8):914-7. doi: 10.1136/jnnp-2013-305587. Epub 2013 Sep 11.
10
A Gne knockout mouse expressing human GNE D176V mutation develops features similar to distal myopathy with rimmed vacuoles or hereditary inclusion body myopathy.表达人类GNE D176V突变的Gne基因敲除小鼠出现与边缘空泡性远端肌病或遗传性包涵体肌病相似的特征。
Hum Mol Genet. 2007 Nov 15;16(22):2669-82. doi: 10.1093/hmg/ddm220. Epub 2007 Aug 18.

引用本文的文献

1
GNE myopathy: History, etiology, and treatment trials.GNE肌病:历史、病因及治疗试验。
Front Neurol. 2022 Oct 18;13:1002310. doi: 10.3389/fneur.2022.1002310. eCollection 2022.
2
The role of amyloid β in the pathological mechanism of GNE myopathy.淀粉样蛋白 β 在 GNE 肌病病理机制中的作用。
Neurol Sci. 2022 Nov;43(11):6309-6321. doi: 10.1007/s10072-022-06301-7. Epub 2022 Jul 29.
3
Population Pharmacokinetic Model of N-acetylmannosamine (ManNAc) and N-acetylneuraminic acid (Neu5Ac) in Subjects with GNE Myopathy.GNE 肌病患者中 N-乙酰甘露糖胺(ManNAc)和 N-乙酰神经氨酸(Neu5Ac)的群体药代动力学模型。
Drugs R D. 2021 Jun;21(2):189-202. doi: 10.1007/s40268-021-00343-6. Epub 2021 Apr 24.
4
Congenital thrombocytopenia associated with GNE mutations in twin sisters: a case report and literature review.先天性血小板减少症与双胞胎姐妹的 GNE 突变相关:病例报告及文献复习。
BMC Med Genet. 2020 Nov 16;21(1):224. doi: 10.1186/s12881-020-01163-2.
5
GNE Myopathy: Etiology, Diagnosis, and Therapeutic Challenges.GNE 肌病:病因、诊断和治疗挑战。
Neurotherapeutics. 2018 Oct;15(4):900-914. doi: 10.1007/s13311-018-0671-y.

本文引用的文献

1
Safety, pharmacokinetics and sialic acid production after oral administration of N-acetylmannosamine (ManNAc) to subjects with GNE myopathy.GNE 肌病患者口服 N-乙酰甘露糖胺(ManNAc)后的安全性、药代动力学和唾液酸生成。
Mol Genet Metab. 2017 Sep;122(1-2):126-134. doi: 10.1016/j.ymgme.2017.04.010. Epub 2017 Apr 26.
2
A sensitive, reproducible and objective immunofluorescence analysis method of dystrophin in individual fibers in samples from patients with duchenne muscular dystrophy.一种用于杜氏肌营养不良症患者样本中单个肌纤维肌营养不良蛋白的灵敏、可重复且客观的免疫荧光分析方法。
PLoS One. 2014 Sep 22;9(9):e107494. doi: 10.1371/journal.pone.0107494. eCollection 2014.
3
Sialylation of Thomsen-Friedenreich antigen is a noninvasive blood-based biomarker for GNE myopathy.桑德森-弗里德赖希抗原的唾液酸化是一种用于诊断GNE肌病的非侵入性血液生物标志物。
Biomark Med. 2014;8(5):641-52. doi: 10.2217/bmm.14.2.
4
GNE myopathy: current update and future therapy.GNE肌病:当前进展与未来治疗
J Neurol Neurosurg Psychiatry. 2015 Apr;86(4):385-92. doi: 10.1136/jnnp-2013-307051. Epub 2014 Jul 7.
5
Mutation update for GNE gene variants associated with GNE myopathy.与GNE肌病相关的GNE基因突变更新
Hum Mutat. 2014 Aug;35(8):915-26. doi: 10.1002/humu.22583.
6
Oral monosaccharide therapies to reverse renal and muscle hyposialylation in a mouse model of GNE myopathy.口服单糖疗法可逆转 GNE 肌病小鼠模型的肾脏和肌肉低唾液酸化。
Mol Genet Metab. 2012 Dec;107(4):748-55. doi: 10.1016/j.ymgme.2012.10.011. Epub 2012 Oct 18.
7
Quantification of dystrophin immunofluorescence in dystrophinopathy muscle specimens.肌营养不良症肌肉标本中抗肌萎缩蛋白免疫荧光定量分析。
Neuropathol Appl Neurobiol. 2012 Oct;38(6):591-601. doi: 10.1111/j.1365-2990.2012.01250.x.
8
Muscular dystrophies due to glycosylation defects: diagnosis and therapeutic strategies.由于糖基化缺陷引起的肌肉萎缩症:诊断和治疗策略。
Curr Opin Neurol. 2011 Oct;24(5):437-42. doi: 10.1097/WCO.0b013e32834a95e3.
9
Ganglioside GM3 levels are altered in a mouse model of HIBM: GM3 as a cellular marker of the disease.神经节苷脂 GM3 水平在 HIBM 小鼠模型中发生改变:GM3 作为该疾病的细胞标志物。
PLoS One. 2010 Apr 7;5(4):e10055. doi: 10.1371/journal.pone.0010055.
10
Clinical features, lectin staining, and a novel GNE frameshift mutation in hereditary inclusion body myopathy.遗传性包涵体肌病的临床特征、凝集素染色及一种新的GNE移码突变
Clin Neuropathol. 2010 Mar-Apr;29(2):71-7.